Covid19 Vaccine

Covid19 Vaccine News

WHO clears Novavax as 10th authorised COVID-19 jab: From efficacy to side-effects, all you need to know about vaccine
Health

WHO clears Novavax as 10th authorised COVID-19 jab: From efficacy to side-effects, all you need to know about vaccine

Nuvaxovid, made from a more conventional technology than others already approved, is likely to help persuade those hesitant about vaccination to come forward

Science behind Vaccines: You don’t need to worry about COVID vaccines being ‘unnatural’ or ‘synthetic’
science

Science behind Vaccines: You don’t need to worry about COVID vaccines being ‘unnatural’ or ‘synthetic’

The mRNA vaccines are the first synthetic vaccines and it is a temporary genetic instruction that tells our cells to make a particular protein.

Centre allows foreign nationals to register for COVID-19 vaccine on CoWin portal; check details here
India

Centre allows foreign nationals to register for COVID-19 vaccine on CoWin portal; check details here

The beneficiaries would need to be registered on the CoWin portal and they can do so by using their passport as an identity document for registration

COVID-19 news: Third wave unlikely to impact children more, claims AIIMS-WHO study; India logs 67,208 cases
India

COVID-19 news: Third wave unlikely to impact children more, claims AIIMS-WHO study; India logs 67,208 cases

The US Centers for Disease Control and Prevention has classified the Delta, a highly transmissible COVID-19 variant first identified in India, as a “variant of concern”

COVID-19 news update: Centre defends increasing gap between doses; report claims 'underreporting' of deaths in Chennai
India

COVID-19 news update: Centre defends increasing gap between doses; report claims 'underreporting' of deaths in Chennai

On the vaccine front, India's vaccination drive seemed set to get another push with SII announcing that it hopes to launch Novavax’s COVID-19 vaccine ‘Covovax’ in India by September

RDIF, Panacea Biotec launch production of Sputnik V vaccine in India; set to produce 10 mn doses per year
India

RDIF, Panacea Biotec launch production of Sputnik V vaccine in India; set to produce 10 mn doses per year

The first batch of the COVID-19 vaccine produced at Panacea Biotec's facilities at Baddi in Himachal Pradesh will be shipped to Russia's Gamaleya Center for quality control

Discussions on with Indian govt for expedited approval of COVID-19 vaccine, says Pfizer
India

Discussions on with Indian govt for expedited approval of COVID-19 vaccine, says Pfizer

CEO Albert Bourla said that Pfizer is aware that 'access to vaccines is critical'. "Unfortunately, our vaccine is not registered in India although our application was submitted months ago," the CEO added

COVID-19 vaccine data analysis: At current rate of 2.2mn doses per day, India can only cover 30% population by end-2021
India

COVID-19 vaccine data analysis: At current rate of 2.2mn doses per day, India can only cover 30% population by end-2021

Free universal vaccination across classes and regions may be the only way to ensure maximum coverage

COVID-19 vaccine: Bharat Biotech to boost Covaxin production to 700 million doses per year
India

COVID-19 vaccine: Bharat Biotech to boost Covaxin production to 700 million doses per year

According to a press release issued by the Hyderabad-based vaccine maker, manufacturing scale-up has been carried out in a stepwise manner across multiple facilities at Hyderabad and Bangalore

WHO rejects SII’s proposal seeking extension of Covishield’s shelf life from 6 to 9 months
India

WHO rejects SII’s proposal seeking extension of Covishield’s shelf life from 6 to 9 months

The UN body has also sought a meeting with the Drugs Controller General of India to discuss the matter 10:12

COVID-19: Pfizer-BioNTech vaccine 100% effective in 12 to 15-year-olds, say companies
World

COVID-19: Pfizer-BioNTech vaccine 100% effective in 12 to 15-year-olds, say companies

Phase 3 trials carried out on 2,260 adolescents in the United States "demonstrated 100 percent efficacy and robust antibody responses", the companies said in a statement

AstraZeneca revises COVID-19 vaccine efficacy to 76% after US panel flags issues
World

AstraZeneca revises COVID-19 vaccine efficacy to 76% after US panel flags issues

The revised figures comes a day after an independent panel in the US accused AstraZeneca of cherry-picking data in determining the protection offered by its vaccine

Hong Kong, Macau suspend use of Pfizer-BioNTech COVID-19 vaccine over defective lids
World

Hong Kong, Macau suspend use of Pfizer-BioNTech COVID-19 vaccine over defective lids

Hong Kong govt has said the suspension was immediate while the matter is investigated by distributor Fosun Pharma and BioNTech, the German company that created the vaccine with American pharmaceutical firm Pfizer

Over 3.25 million vaccine doses administered on 22 March, highest single-day vaccination so far, says Centre
India

Over 3.25 million vaccine doses administered on 22 March, highest single-day vaccination so far, says Centre

Out of these, 29,03,030 beneficiaries were vaccinated across 48,345 sessions for the first dose and 3,50,065 healthcare workers (HCWs) and frontline workers (FLWs) received the second dose of vaccine

Moderna kicks off COVID-19 vaccine trials in children aged 6 months to under 12 years
World

Moderna kicks off COVID-19 vaccine trials in children aged 6 months to under 12 years

"This pediatric study will help us assess the potential safety and immunogenicity of our COVID-19 vaccine candidate in this important younger age population," said CEO Stephane Bancel in a statement

China to issue visas to foreigners, including Indians, if they have taken Chinese COVID-19 vaccine
World

China to issue visas to foreigners, including Indians, if they have taken Chinese COVID-19 vaccine

The embassy statement said the new rule applied to those who had either had two doses of the vaccine or a single-dose at least 14 days before applying for the visa

Germany approves AstraZeneca COVID-19 vaccine for citizens over 65 years of age
World

Germany approves AstraZeneca COVID-19 vaccine for citizens over 65 years of age

The country had previously cited lack of sufficient data to greenlight the vaccine for older people

Coronavirus News Updates: Glitches, OTP delays reported on Day 1 of vaccine rollout; President Kovind, PM, Amit Shah take first dose of Covaxin
India

Coronavirus News Updates: Glitches, OTP delays reported on Day 1 of vaccine rollout; President Kovind, PM, Amit Shah take first dose of Covaxin

Coronavirus News LIVE Updates: India launched phase 3 of its Covid-19 vaccination drive on Monday benefiting everyone above the age of 60 and those within the age bracket of 45-59 with comorbidities to get vaccinated

Phase 2 of COVID-19 vaccination drive: Narendra Modi takes first dose of Covaxin; CoWin glitches, delays mark rollout
India

Phase 2 of COVID-19 vaccination drive: Narendra Modi takes first dose of Covaxin; CoWin glitches, delays mark rollout

India's coronavirus case count went past 1.11 crore on Monday with 15,510 new infections, while the active cases registered an increase for the fifth consecutive day

UK'S COVID-19 vaccine rollout enters new phase, expands to inoculate those above 60 years
World

UK'S COVID-19 vaccine rollout enters new phase, expands to inoculate those above 60 years

Almost 2 million people aged 60 to 63 will be invited from Monday, with letters explaining how they can make an appointment for the jab